Fine Treatment praises business growth in Oxford

Fine Treatment, a British R&D and medtech company, praises the Oxfordshire Local Enterprise Partnership (OxLEP) for providing the much-needed business growth support to high-impact SMEs enabling their continued scientific research and product innovation.

Funded by the European Regional Development Fund, the Innovation Support for Business (ISfB) programme implemented by OxLEP, has enabled Fine Treatment to expand its medical research activities for improved out-of-hospital patient care.

Fine Treatment’s Thermobalancing therapy with Dr Allen’s Devices is a life-changing treatment designed for different chronic health conditions. Dr Allen’s Device is proven to treat prostate enlargement, known as benign prostatic hyperplasia (BPH), chronic prostatitis, low back pain, and kidney stones up to full recovery and without any side effects.

Further information about multiple advantages of Dr Allen’s Devices compared to other treatment options can be found here: